Loading company…
Australia-based Vexev develops VxWave, an autonomous ultrasound system for vascular access assessment in dialysis patients.
Based in Australia, Vexev Pty Ltd was co-founded in 2018 by Dr John Carroll and Dr Eamonn Colley and develops vascular imaging technology. Its VxWave product is an autonomous ultrasound system that uses robotics, machine learning and ultrasound to assess and monitor vascular access, including for dialysis patients. In August 2026, the company raised USD 6 million in venture funding from TreeArc Investment Group, TEN13, Bioshore Ventures, Alumni Ventures, Blackbird Ventures, Neotribe Ventures, Startmate and Horizon. The funds are planned for regulatory work, manufacturing scale-up and commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in